Penn Medicine Provider
Medical Oncology
Courtney A. Gabriel, MD, MSCE
5.0
(569)
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Cherry Hill

What my patients think about me

Average Rating
5.0

570 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
thorough exam
April 2025
5.0
5.0
she's thorough and friendly.
April 2025
5.0
5.0
knowledgeable
April 2025
5.0
5.0
her genuine concern for me as her patient

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Gabriel is a Penn Medicine physician. In New Jersey, providers are affiliated with Penn Medicine through Clinical Health Care Associates of New Jersey or Princeton Healthcare Affiliated Physicians, PC.

Qualifications and experience

My research

Yash B. Shah, Ping Lin, Stone Chen, Alan Zheng, Wendy Alcaraz, Meghan C. Towne, Courtney Gabriel, Elizabeth J. Bhoj, Michele P. Lambert, Timothy S. Olson, Dale M. Frank, Colin A. Ellis, Daria V. Babushok Inherited bone marrow failure with macrothrombocytopenia due to germline tubulin beta class I (TUBB) variant , British Journal of Haematology, 200(2): 2023,222-228


Gabriel CA, Mitra N, Demichele A, Rebbeck T Association of progesterone receptor gene (PGR) variants and breast cancer risk in African American women. , Breast Cancer Res Treat, 139(3): 2013.,833-43


Nakashima MO, Roy DB, Nagamine M, Roullet MR, Gabriel CA, Sood SL, Bagg A Intravascular large B-cell lymphoma: a mimicker of many maladies and a difficult and often delayed diagnosis. , J Clin Oncol, 29(6): 2011.,e138-40


Gabriel C, Sun W Treatment of advanced hepatocellular carcinoma: Sorafenib and beyond , Clin Med Rev Oncol, 3: 2011.,39-47


Gabriel CA, Domchek SM Breast cancer in young women. , Breast Cancer Res, 12(5): 2010.,212


Gabriel C A, Tigges-Cardwell J, Stopfer J, Erlichman J, Nathanson K, Domchek S M Use of total abdominal hysterectomy and hormone replacement therapy in BRCA1 and BRCA2 mutation carriers undergoing risk-reducing salpingo-oophorectomy. , Fam Cancer, 8(1): 2009.,23-8


Lowe M, Madsen EL, Schindler K, Smith C, Emrich S, Robb F, Halden R. Geochemistry and microbial diversity of a trichloroethene-contaminated Superfund site undergoing intrinsic in situ reductive dechlorination. , FEMS Microbiol Ecol, 40(2): 2002.,123-134